Emerging therapeutic targets for cardiac arrhythmias: role of STAT3 in regulating cardiac fibroblast function

References

• Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the american heart association. Circulation. 2019;139:e56–e528.
   PubMed Web of Science ®Google Scholar
• Travers JG, Kamal FA, Robbins J, et al. Cardiac fibrosis: the fibroblast awakens. Circ Res. 2016;118:1021–1040.
   PubMed Web of Science ®Google Scholar
• Kohl P, Gourdie RG. Fibroblast-myocyte electrotonic coupling: does it occur in native cardiac tissue? J Mol Cell Cardiol. 2014;70:37–46.
   PubMed Web of Science ®Google Scholar
• Vasquez C, Benamer N, Morley GE. The cardiac fibroblast: functional and electrophysiological considerations in healthy and diseased hearts. J Cardiovasc Pharmacol. 2011;57:380–388.
   PubMed Web of Science ®Google Scholar
• Tallquist MD, Molkentin JD. Redefining the identity of cardiac fibroblasts. Nat Rev Cardiol. 2017;14:484–491.
   PubMed Web of Science ®Google Scholar
• Humeres C, Frangogiannis NG. Fibroblasts in the infarcted, remodeling, and failing heart. JACC Basic Transl Sci. 2019;4:449–467.
   PubMedGoogle Scholar
• Rohr S. Myofibroblasts in diseased hearts: new players in cardiac arrhythmias? Heart Rhythm. 2009;6:848–856.
   PubMed Web of Science ®Google Scholar
• Davis J, Molkentin JD. Myofibroblasts: trust your heart and let fate decide. J Mol Cell Cardiol. 2014;70:9–18.
   PubMed Web of Science ®Google Scholar
• Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 2014;71:549–574.
   PubMed Web of Science ®Google Scholar
• Fu X, Khalil H, Kanisicak O, et al. Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. J Clin Invest. 2018;128:2127–2143.
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Aspects Med. 2019;65:70–99.
   PubMed Web of Science ®Google Scholar
• Saucerman JJ, Tan PM, Buchholz KS, et al. Mechanical regulation of gene expression in cardiac myocytes and fibroblasts. Nat Rev Cardiol. 2019;16:361–378.
   PubMed Web of Science ®Google Scholar
• Zeigler AC, Richardson WJ, Holmes JW, et al. A computational model of cardiac fibroblast signaling predicts context-dependent drivers of myofibroblast differentiation. J Mol Cell Cardiol. 2016;94:72–81.
   PubMed Web of Science ®Google Scholar
• Harhous Z, Booz GW, Ovize M, et al. An update on the multifaceted roles of STAT3 in the heart. Front Cardiovasc Med. 2019;6:150.
   PubMed Web of Science ®Google Scholar
• Unudurthi SD, Nassal D, Greer-Short A, et al. betaIV-Spectrin regulates STAT3 targeting to tune cardiac response to pressure overload. J Clin Invest. 2018;128:5561–5572.
   PubMed Web of Science ®Google Scholar
• Hutchins AP, Diez D, Miranda-Saavedra D. Genomic and computational approaches to dissect the mechanisms of STAT3’s universal and cell type-specific functions. JAKSTAT. 2013;2:e25097.
   PubMedGoogle Scholar
• Kishore R, Verma SK. Roles of STATs signaling in cardiovascular diseases. JAKSTAT. 2012;1:118–124.
   PubMedGoogle Scholar
• Haghikia A, Stapel B, Hoch M, et al. STAT3 and cardiac remodeling. Heart Fail Rev. 2011;16:35–47.
   PubMed Web of Science ®Google Scholar
• Haghikia A, Ricke-Hoch M, Stapel B, et al. STAT3, a key regulator of cell-to-cell communication in the heart. Cardiovasc Res. 2014;102:281–289.
   PubMed Web of Science ®Google Scholar
• Bousoik E, Montazeri Aliabadi H. “Do we know jack” about JAK? A closer look at JAK/STAT signaling pathway. Front Oncol. 2018;8:287.
   PubMed Web of Science ®Google Scholar
• Zouein FA, Altara R, Chen Q, et al. Pivotal importance of STAT3 in protecting the heart from acute and chronic stress: new advancement and unresolved issues. Front Cardiovasc Med. 2015;2:36.
   PubMedGoogle Scholar
• Wakahara R, Kunimoto H, Tanino K, et al. Phospho-Ser727 of STAT3 regulates STAT3 activity by enhancing dephosphorylation of phospho-Tyr705 largely through TC45. Genes Cells. 2012;17:132–145.
   PubMed Web of Science ®Google Scholar
• Wegrzyn J, Potla R, Chwae YJ, et al. Function of mitochondrial Stat3 in cellular respiration. Science. 2009;323:793–797.
   PubMed Web of Science ®Google Scholar
• Zouein FA, Zgheib C, Hamza S, et al. Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation. Hypertens Res. 2013;36:496–503.
   PubMed Web of Science ®Google Scholar
• Yang J, Liao X, Agarwal MK, et al. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev. 2007;21:1396–1408.
   PubMed Web of Science ®Google Scholar
• Yue H, Li W, Desnoyer R, et al. Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy. Cardiovasc Res. 2010;85:90–99.
   PubMed Web of Science ®Google Scholar
• Lee JL, Wang MJ, Chen JY. Acetylation and activation of STAT3 mediated by nuclear translocation of CD44. J Cell Biol. 2009;185:949–957.
   PubMed Web of Science ®Google Scholar
• Melendez GC, McLarty JL, Levick SP, et al. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension. 2010;56:225–231.
   PubMed Web of Science ®Google Scholar
• Hilfiker-Kleiner D, Shukla P, Klein G, et al. Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction. Circulation. 2010;122:145–155.
   PubMed Web of Science ®Google Scholar
• Biernacka A, Dobaczewski M, Frangogiannis NG. TGF-beta signaling in fibrosis. Growth Factors. 2011;29:196–202.
   PubMed Web of Science ®Google Scholar
• Khalil H, Kanisicak O, Prasad V, et al. Fibroblast-specific TGF-beta-Smad2/3 signaling underlies cardiac fibrosis. J Clin Invest. 2017;127:3770–3783.
   PubMed Web of Science ®Google Scholar
• Small EM, Thatcher JE, Sutherland LB, et al. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res. 2010;107:294–304.
   PubMed Web of Science ®Google Scholar
• Stempien-Otero A, Kim DH, Davis J. Molecular networks underlying myofibroblast fate and fibrosis. J Mol Cell Cardiol. 2016;97:153–161.
   PubMed Web of Science ®Google Scholar
• Stambe C, Atkins RC, Tesch GH, et al. The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol. 2004;15:370–379.
   PubMed Web of Science ®Google Scholar
• Wang L, Ma R, Flavell RA, et al. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells. J Biol Chem. 2002;277:47257–47262.
   PubMed Web of Science ®Google Scholar
• Chakraborty D, Sumova B, Mallano T, et al. Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis. Nat Commun. 2017;8:1130.
   PubMed Web of Science ®Google Scholar
• Dees C, Potter S, Zhang Y, et al. TGF-beta-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis. J Clin Invest. 2020;130:2347–2363.
   PubMed Web of Science ®Google Scholar
• O’Reilly S, Ciechomska M, Cant R, et al. Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-beta (TGF-beta) signaling promoting SMAD3 activation and fibrosis via Gremlin protein. J Biol Chem. 2014;289:9952–9960.
   PubMed Web of Science ®Google Scholar
• Su SA, Yang D, Wu Y, et al. EphrinB2 regulates cardiac fibrosis through modulating the interaction of Stat3 and TGF-beta/Smad3 signaling. Circ Res. 2017;121:617–627.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zhang Y, Han X, et al. Relaxin alleviates TGFbeta1-induced cardiac fibrosis via inhibition of Stat3-dependent autophagy. Biochem Biophys Res Commun. 2017;493:1601–1607.
   PubMed Web of Science ®Google Scholar
• Civitarese RA, Kapus A, McCulloch CA, et al. Role of integrins in mediating cardiac fibroblast-cardiomyocyte cross talk: a dynamic relationship in cardiac biology and pathophysiology. Basic Res Cardiol. 2017;112:6.
   PubMed Web of Science ®Google Scholar
• Schroer AK, Merryman WD. Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease. J Cell Sci. 2015;128:1865–1875.
   PubMed Web of Science ®Google Scholar
• Baker EL, Zaman MH. The biomechanical integrin. J Biomech. 2010;43:38–44.
   PubMed Web of Science ®Google Scholar
• Chen C, Li R, Ross RS, et al. Integrins and integrin-related proteins in cardiac fibrosis. J Mol Cell Cardiol. 2016;93:162–174.
   PubMed Web of Science ®Google Scholar
• Humphries JD, Byron A, Humphries MJ. Integrin ligands at a glance. J Cell Sci. 2006;119:3901–3903.
   PubMed Web of Science ®Google Scholar
• Gullberg D, Gehlsen KR, Turner DC, et al. Analysis of alpha 1 beta 1, alpha 2 beta 1 and alpha 3 beta 1 integrins in cell–collagen interactions: identification of conformation dependent alpha 1 beta 1 binding sites in collagen type I. Embo J. 1992;11:3865–3873.
   PubMed Web of Science ®Google Scholar
• Popova SN, Barczyk M, Tiger CF, et al. Alpha11 beta1 integrin-dependent regulation of periodontal ligament function in the erupting mouse incisor. Mol Cell Biol. 2007;27:4306–4316.
   PubMed Web of Science ®Google Scholar
• Balasubramanian S, Quinones L, Kasiganesan H, et al. beta3 integrin in cardiac fibroblast is critical for extracellular matrix accumulation during pressure overload hypertrophy in mouse. PLoS One. 2012;7:e45076.
   PubMed Web of Science ®Google Scholar
• Sarrazy V, Koehler A, Chow ML, et al. Integrins alphavbeta5 and alphavbeta3 promote latent TGF-beta1 activation by human cardiac fibroblast contraction. Cardiovasc Res. 2014;102:407–417.
   PubMed Web of Science ®Google Scholar
• Hamzeh MT, Sridhara R, Alexander LD. Cyclic stretch-induced TGF-beta1 and fibronectin expression is mediated by beta1-integrin through c-Src- and STAT3-dependent pathways in renal epithelial cells. Am J Physiol Renal Physiol. 2015;308:F425–36.
   PubMed Web of Science ®Google Scholar
• Pechkovsky DV, Prele CM, Wong J, et al. STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF. Am J Pathol. 2012;180:1398–1412.
   PubMed Web of Science ®Google Scholar
• Boopathy GTK, Hong W. Role of hippo pathway-YAP/TAZ signaling in angiogenesis. Front Cell Dev Biol. 2019;7:49.
   PubMed Web of Science ®Google Scholar
• Halder G, Johnson RL. Hippo signaling: growth control and beyond. Development. 2011;138:9–22.
   PubMed Web of Science ®Google Scholar
• Del Re DP. Beyond the cardiomyocyte: consideration of HIPPO pathway cell-type specificity. Circ Res. 2018;123:30–32.
   PubMed Web of Science ®Google Scholar
• Sun M, Spill F, Zaman MH. A computational model of YAP/TAZ mechanosensing. Biophys J. 2016;110:2540–2550.
   PubMed Web of Science ®Google Scholar
• Aragona M, Panciera T, Manfrin A, et al. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell. 2013;154:1047–1059.
   PubMed Web of Science ®Google Scholar
• Liu F, Lagares D, Choi KM, et al. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am J Physiol Lung Cell Mol Physiol. 2015;308:L344–57.
   PubMed Web of Science ®Google Scholar
• Jin B, Zhu J, Shi HM, et al. YAP activation promotes the transdifferentiation of cardiac fibroblasts to myofibroblasts in matrix remodeling of dilated cardiomyopathy. Braz J Med Biol Res. 2018;52:e7914.
   PubMed Web of Science ®Google Scholar
• Ebrahimighaei R, McNeill MC, Smith SA, et al. Elevated cyclic-AMP represses expression of exchange protein activated by cAMP (EPAC1) by inhibiting YAP-TEAD activity and HDAC-mediated histone deacetylation. Biochim Biophys Acta Mol Cell Res. 2019;1866:1634–1649.
   PubMed Web of Science ®Google Scholar
• Mo JS, Meng Z, Kim YC, et al. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat Cell Biol. 2015;17:500–510.
   PubMed Web of Science ®Google Scholar
• Pan J, Fukuda K, Saito M, et al. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res. 1999;84:1127–1136.
   PubMed Web of Science ®Google Scholar
• He J, Bao Q, Zhang Y, et al. Yes-associated protein promotes angiogenesis via signal transducer and activator of transcription 3 in endothelial cells. Circ Res. 2018;122:591–605.
   PubMed Web of Science ®Google Scholar
• Du YE, Tu G, Yang G, et al. MiR-205/YAP1 in activated fibroblasts of breast tumor promotes VEGF-independent angiogenesis through STAT3 signaling. Theranostics. 2017;7:3972–3988.
   PubMed Web of Science ®Google Scholar
• Gruber R, Panayiotou R, Nye E, et al. YAP1 and TAZ control pancreatic cancer initiation in mice by direct up-regulation of JAK-STAT3 signaling. Gastroenterology. 2016;151:526–539.
   PubMed Web of Science ®Google Scholar
• Olson EN, Nordheim A. Linking actin dynamics and gene transcription to drive cellular motile functions. Nat Rev Mol Cell Biol. 2010;11:353–365.
   PubMed Web of Science ®Google Scholar
• Janmey PA, Wells RG, Assoian RK, et al. From tissue mechanics to transcription factors. Differentiation. 2013;86:112–120.
   PubMed Web of Science ®Google Scholar
• Huang X, Yang N, Fiore VF, et al. Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction. Am J Respir Cell Mol Biol. 2012;47:340–348.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Liao JK. Rho kinases and cardiac remodeling. Circ J. 2016;80:1491–1498.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Narang N, Chen P, et al. Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction. JCI Insight. 2017;2:e93187.
   Web of Science ®Google Scholar
• Oh RS, Haak AJ, Smith KMJ, et al. RNAi screening identifies a mechanosensitive ROCK-JAK2-STAT3 network central to myofibroblast activation. J Cell Sci. 2018;131:jcs209932.
   PubMed Web of Science ®Google Scholar
• Unudurthi SD, Greer-Short A, Patel N, et al. Spectrin-based pathways underlying electrical and mechanical dysfunction in cardiac disease. Expert Rev Cardiovasc Ther. 2018;16:59–65.
   PubMed Web of Science ®Google Scholar
• Baines AJ, Pinder JC. The spectrin-associated cytoskeleton in mammalian heart. Front Biosci. 2005;10:3020–3033.
   PubMedGoogle Scholar
• Bennett V, Baines AJ. Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. Physiol Rev. 2001;81:1353–1392.
   PubMed Web of Science ®Google Scholar
• Bennett V, Lorenzo DN. Spectrin- and ankyrin-based membrane domains and the evolution of vertebrates. Curr Top Membr. 2013;72:1–37.
   PubMed Web of Science ®Google Scholar
• Hashemi SM, Hund TJ, Mohler PJ. Cardiac ankyrins in health and disease. J Mol Cell Cardiol. 2009;47:203–209.
   PubMed Web of Science ®Google Scholar
• Tang Y, Katuri V, Dillner A, et al. Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. Science. 2003;299:574–577.
   PubMed Web of Science ®Google Scholar
• Lim JA, Baek HJ, Jang MS, et al. Loss of beta2-spectrin prevents cardiomyocyte differentiation and heart development. Cardiovasc Res. 2014;101:39–47.
   PubMed Web of Science ®Google Scholar
• Piersma B, Wouters OY, Bank RA. AlphaII-spectrin and betaII-spectrin do not affect TGFbeta1-induced myofibroblast differentiation. Cell Tissue Res. 2018;374:165–175.
   PubMed Web of Science ®Google Scholar
• Lin L, Yao Z, Bhuvaneshwar K, et al. Transcriptional regulation of STAT3 by SPTBN1 and SMAD3 in HCC through cAMP-response element-binding proteins ATF3 and CREB2. Carcinogenesis. 2014;35:2393–2403.
   PubMed Web of Science ®Google Scholar
• Patel NJ, Nassal DM, Greer-Short AD, et al. betaIV-Spectrin/STAT3 complex regulates fibroblast phenotype, fibrosis, and cardiac function. JCI Insight. 2019;4:e131046.
   Web of Science ®Google Scholar
• Hund TJ, Koval OM, Li J, et al. A betaIV spectrin/CaMKII signaling complex is essential for membrane excitability in mice. J Clin Invest. 2010;120:3508–3519.
   PubMed Web of Science ®Google Scholar
• Martin TP, Lawan A, Robinson E, et al. Adult cardiac fibroblast proliferation is modulated by calcium/calmodulin-dependent protein kinase II in normal and hypertrophied hearts. Pflugers Arch. 2014;466:319–330.
   PubMed Web of Science ®Google Scholar
• Zhang W, Chen DQ, Qi F, et al. Inhibition of calcium-calmodulin-dependent kinase II suppresses cardiac fibroblast proliferation and extracellular matrix secretion. J Cardiovasc Pharmacol. 2010;55:96–105.
   PubMed Web of Science ®Google Scholar
• Huang Z, Chen XJ, Qian C, et al. Signal transducer and activator of transcription 3/MicroRNA-21 feedback loop contributes to atrial fibrillation by promoting atrial fibrosis in a rat sterile pericarditis model. Circ Arrhythm Electrophysiol. 2016;9:e003396.
   PubMed Web of Science ®Google Scholar
• Chen Y, Surinkaew S, Naud P, et al. JAK-STAT signaling and the atrial fibrillation promoting fibrotic substrate. Cardiovasc Res. 2017;113:310–320.
   PubMed Web of Science ®Google Scholar
• Tsai CT, Lin JL, Lai LP, et al. Membrane translocation of small GTPase Rac1 and activation of STAT1 and STAT3 in pacing-induced sustained atrial fibrillation. Heart Rhythm. 2008;5:1285–1293.
   PubMed Web of Science ®Google Scholar
• Xue XD, Huang JH, Wang HS. Angiotensin II activates signal transducers and activators of transcription 3 via Rac1 in the atrial tissue in permanent atrial fibrillation patients with rheumatic heart disease. Cell Biochem Biophys. 2015;71:205–213.
   PubMed Web of Science ®Google Scholar
• Chang SH, Yeh YH, Lee JL, et al. Transforming growth factor-beta-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation. Basic Res Cardiol. 2017;112:58.
   PubMed Web of Science ®Google Scholar
• Yajima T, Murofushi Y, Zhou H, et al. Absence of SOCS3 in the cardiomyocyte increases mortality in a gp130-dependent manner accompanied by contractile dysfunction and ventricular arrhythmias. Circulation. 2011;124:2690–2701.
   PubMed Web of Science ®Google Scholar
• Brar BK, Stephanou A, Liao Z, et al. Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation. Cardiovasc Res. 2001;51:265–274.
   PubMed Web of Science ®Google Scholar
• Zou Y, Takano H, Mizukami M, et al. Leukemia inhibitory factor enhances survival of cardiomyocytes and induces regeneration of myocardium after myocardial infarction. Circulation. 2003;108:748–753.
   PubMed Web of Science ®Google Scholar
• Obana M, Maeda M, Takeda K, et al. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction. Circulation. 2010;121:684–691.
   PubMed Web of Science ®Google Scholar
• Oba T, Yasukawa H, Hoshijima M, et al. Cardiac-specific deletion of SOCS-3 prevents development of left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol. 2012;59:838–852.
   PubMed Web of Science ®Google Scholar
• Obana M, Miyamoto K, Murasawa S, et al. Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart. Am J Physiol Heart Circ Physiol. 2012;303:H569–77.
   PubMed Web of Science ®Google Scholar
• Pipicz M, Demjan V, Sarkozy M, et al. Effects of cardiovascular risk factors on cardiac STAT3. Int J Mol Sci. 2018;19:3572.
   Web of Science ®Google Scholar
• Zgheib C, Zouein FA, Kurdi M, et al. Differential STAT3 signaling in the heart: impact of concurrent signals and oxidative stress. JAKSTAT. 2012;1:101–110.
   Google Scholar
• Cheon H, Yang J, Stark GR. The functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins. J Interferon Cytokine Res. 2011;31:33–40.
   PubMed Web of Science ®Google Scholar
• Arany I, Reed DK, Grifoni SC, et al. A novel U-STAT3-dependent mechanism mediates the deleterious effects of chronic nicotine exposure on renal injury. Am J Physiol Renal Physiol. 2012;302:F722–9.
   PubMed Web of Science ®Google Scholar
• Mir SA, Chatterjee A, Mitra A, et al. Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart. J Biol Chem. 2012;287:2666–2677.
   Google Scholar
• Bao Q, Zhang B, Suo Y, et al. Intermittent hypoxia mediated by TSP1 dependent on STAT3 induces cardiac fibroblast activation and cardiac fibrosis. Elife. 2020;9:e49923.
   PubMed Web of Science ®Google Scholar
• Enomoto D, Obana M, Miyawaki A, et al. Cardiac-specific ablation of the STAT3 gene in the subacute phase of myocardial infarction exacerbated cardiac remodeling. Am J Physiol Heart Circ Physiol. 2015;309:H471–80.
   PubMed Web of Science ®Google Scholar